|Articles|November 15, 2001
- BioPharm International-11-01-2001
- Volume 14
- Issue 11
Outsourcing Outlook: Truth in Outsourcing
Author(s)Jim Miller, William Bierce
by William Bierce and Jim Miller Is that great deal too good to be true?
Advertisement
Articles in this issue
about 24 years ago
Business Matters: Eclipsed by Catastropheabout 24 years ago
Designs for Bioassays with Plate Location Effectsabout 24 years ago
Liposomes (a Review), Part One: Manufacturing Issuesabout 24 years ago
Simplifying Pharmacologic Analysis with Programmable Scientific SoftwareNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Developing Next-Gen Cell Lines Using Targeted Integration
2
FDA-Approved WAS Gene Therapy Hits Market in Nonprofit Model
3
FAQ: What You Need to Know about the Current Antibody Pipeline
4
Norgine Secures Hepatitis Delta Therapy Rights Across Key Region
5